Similarly, factors such as very high PSA at diagnosis, Gleason scores of 9–10 indicating poorly differentiated tumours, or extensive lymph node involvement may influence treatment decisions toward triplet therapy [34]. This evidence concerns the gene KLK3 and neoplasm.